Free Trial

Cosmos Health (COSM) Competitors

$0.74
+0.04 (+5.71%)
(As of 05/28/2024 ET)

COSM vs. BIMI, MEDS, GHSI, TRIB, AIKI, PSTV, AVTX, MBRX, IKT, and ONMD

Should you be buying Cosmos Health stock or one of its competitors? The main competitors of Cosmos Health include BIMI (BIMI), TRxADE HEALTH (MEDS), Guardion Health Sciences (GHSI), Trinity Biotech (TRIB), AIkido Pharma (AIKI), Plus Therapeutics (PSTV), Avalo Therapeutics (AVTX), Moleculin Biotech (MBRX), Inhibikase Therapeutics (IKT), and OneMedNet (ONMD). These companies are all part of the "medical" sector.

Cosmos Health vs.

BIMI (NASDAQ:BIMI) and Cosmos Health (NASDAQ:COSM) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, media sentiment, analyst recommendations, profitability, earnings, valuation, dividends, institutional ownership and risk.

Cosmos Health has higher revenue and earnings than BIMI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BIMI$11.83M1.06-$22.39MN/AN/A
Cosmos Health$50.35M0.23-$13.83MN/AN/A

Cosmos Health has a net margin of -31.48% compared to Cosmos Health's net margin of -94.58%. BIMI's return on equity of -28.54% beat Cosmos Health's return on equity.

Company Net Margins Return on Equity Return on Assets
BIMI-94.58% -133.29% -33.85%
Cosmos Health -31.48%-28.54%-17.69%

BIMI has a beta of 1.72, meaning that its share price is 72% more volatile than the S&P 500. Comparatively, Cosmos Health has a beta of 5.84, meaning that its share price is 484% more volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BIMI
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Cosmos Health
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

0.1% of BIMI shares are owned by institutional investors. Comparatively, 12.6% of Cosmos Health shares are owned by institutional investors. 69.0% of BIMI shares are owned by insiders. Comparatively, 18.7% of Cosmos Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Cosmos Health had 11 more articles in the media than BIMI. MarketBeat recorded 14 mentions for Cosmos Health and 3 mentions for BIMI. Cosmos Health's average media sentiment score of 0.73 beat BIMI's score of 0.24 indicating that BIMI is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BIMI
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Cosmos Health
1 Very Positive mention(s)
1 Positive mention(s)
9 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

BIMI received 5 more outperform votes than Cosmos Health when rated by MarketBeat users. However, 70.69% of users gave Cosmos Health an outperform vote while only 57.50% of users gave BIMI an outperform vote.

CompanyUnderperformOutperform
BIMIOutperform Votes
46
57.50%
Underperform Votes
34
42.50%
Cosmos HealthOutperform Votes
41
70.69%
Underperform Votes
17
29.31%

Summary

Cosmos Health beats BIMI on 10 of the 14 factors compared between the two stocks.

Get Cosmos Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for COSM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COSM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COSM vs. The Competition

MetricCosmos HealthDrugs, proprietaries, & sundries IndustryMedical SectorNASDAQ Exchange
Market Cap$11.34M$14.66B$4.96B$8.05B
Dividend YieldN/A1.29%2.80%3.96%
P/E RatioN/A15.13120.9414.33
Price / Sales0.231.882,550.2773.57
Price / CashN/A9.7832.5528.77
Price / Book0.1812.344.964.41
Net Income-$13.83M$618.02M$103.73M$213.15M
7 Day Performance-4.29%-1.05%-0.69%-0.67%
1 Month Performance3.08%-0.64%3.66%3.40%
1 Year Performance-77.89%5.79%5.59%7.75%

Cosmos Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIMI
BIMI
0 of 5 stars
$1.22
-10.3%
N/A+18.9%$14.14M$11.83M0.00296Upcoming Earnings
Short Interest ↓
Gap Up
MEDS
TRxADE HEALTH
0 of 5 stars
$5.88
+2.3%
N/A+37.7%$8.29M$8.27M-0.858News Coverage
GHSI
Guardion Health Sciences
0 of 5 stars
$9.27
+17.4%
N/A+43.7%$11.86M$12.25M-2.309News Coverage
TRIB
Trinity Biotech
0 of 5 stars
$1.55
-1.9%
N/A-63.3%$11.81M$56.83M-0.49398Analyst Forecast
Short Interest ↑
Gap Down
AIKI
AIkido Pharma
0 of 5 stars
$2.14
+0.5%
N/A-14.2%$11.74M$10,000.00-0.554Gap Down
PSTV
Plus Therapeutics
2.4644 of 5 stars
$2.13
-2.3%
$8.00
+275.6%
-48.7%$12.14M$4.91M-0.7020Short Interest ↑
Positive News
AVTX
Avalo Therapeutics
0.5538 of 5 stars
$10.92
-1.6%
N/A-98.2%$11.48M$1.45M0.0019Short Interest ↓
Positive News
MBRX
Moleculin Biotech
2.2333 of 5 stars
$4.96
+0.2%
$35.00
+605.6%
-43.2%$11.46MN/A0.0018Positive News
IKT
Inhibikase Therapeutics
1.5657 of 5 stars
$1.89
+1.6%
$23.00
+1,116.9%
-51.0%$12.25M$260,000.00-0.578Gap Up
ONMD
OneMedNet
0 of 5 stars
$0.48
+2.1%
N/AN/A$11.45M$1.02M-2.5320Upcoming Earnings
Short Interest ↓
News Coverage
Positive News
Gap Down

Related Companies and Tools

This page (NASDAQ:COSM) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners